Claudin18.2 bispecific T-cell engager for gastric cancer immunotherapy

被引：0
|
作者：
Pandian, Swarna [1 ]
Li, Zusheng [1 ]
Chan, Eugene [1 ]
Markelewicz, Robert [1 ]
Wyant, Timothy [2 ]
Lakshmikanthan, Sribalaji [2 ]
机构：
[1] Abpro Corp, Woburn, MA USA
[2] AbproCorporation, Lexington, MA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P610
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer
    Xu, Bo
    Chen, Fangjun
    Zhang, Xin
    Wang, Zhongda
    Che, Keying
    Wu, Nandie
    Yu, Lixia
    Fan, Xiangshan
    Liu, Baorui
    Wei, Jia
    CANCERS, 2022, 14 (11)
  • [2] Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer
    Liu, Shiyu
    Li, Fan
    Deng, Li
    Ma, Qiongqiong
    Lu, Wenyi
    Zhao, Zhuoqian
    Liu, Huanzhen
    Zhou, Yixuan
    Hu, Manli
    Wang, Hui
    Yan, Yingbin
    Zhao, Mingfeng
    Zhang, Hongkai
    Du, Mingjuan
    MOLECULAR THERAPY ONCOLYTICS, 2023, 30 : 275 - 285
  • [3] Claudin18.2 in Advanced Gastric Cancer
    Inamoto, Rin
    Takahashi, Naoki
    Yamada, Yasuhide
    CANCERS, 2023, 15 (24)
  • [4] Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancer
    Stieglmaier, Julia
    Benjamin, Jonathan
    Nagorsen, Dirk
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (08) : 1093 - 1099
  • [5] Clinical Implications of Claudin18.2 Expression in Patients With Gastric Cancer
    Baek, Jin Ho
    Park, Dong Jin
    Kim, Gyu Yeol
    Cheon, Jaekyung
    Kang, Byung Woog
    Cha, Hee Jeong
    Kim, Jong Gwang
    ANTICANCER RESEARCH, 2019, 39 (12) : 6973 - 6979
  • [6] Correlation of Claudin18.2 expression with clinicopathological characteristics and prognosis in gastric cancer
    Tao, Daoyu
    Guan, Bingxin
    Li, Zengxian
    Jiao, Meng
    Zhou, Chengjun
    Li, Hui
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [7] Progress of Clinical Studies Targeting Claudin18.2 for the Treatment of Gastric Cancer
    Jin, Wu-mei
    Zhu, Yan
    Cai, Zhi-qiang
    He, Na
    Yu, Zhi-qiong
    Li, Shuang
    Yang, Ji-yuan
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (07) : 2631 - 2647
  • [8] Better performance of pan-claudin18 antibodies on claudin18.2 detection in gastric adenocarcinoma than claudin18.2 specific antibody
    Ni, S.
    Sheng, W.
    Su, W.
    Lu, H.
    Yan, Q.
    Xu, J.
    Hua, C.
    Huang, Z.
    Ruan, L.
    Zhu, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S244 - S245
  • [9] Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy
    Weijie Cao
    Haizhou Xing
    Yingmei Li
    Wenliang Tian
    Yongping Song
    Zhongxing Jiang
    Jifeng Yu
    Biomarker Research, 10
  • [10] T-cell Immunotherapy and Cardiovascular Disease Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies
    Stein-Merlob, Ashley F.
    Ganatra, Sarju
    Yang, Eric H.
    HEART FAILURE CLINICS, 2022, 18 (03) : 443 - 454
12345